Wageningen Bioveterinary Research (WBVR) has licensed a promising vaccination platform technology to Bunyavax B.V. Bunyavax B.V. is headed by Jochem Bossenbroek, an experienced entrepreneur. He holds an Executive MBA from RSM.
This article was also published in Dutch:
www.wur.nl/nl/nieuws-wur/Show/WBVR-verstrekt-patentlicentie-aan-Bunyavax-B.V..htm